New horizons of non-emergent use of extracorporeal membranous oxygenator support

George Makdisi; Peter B Makdisi; I-Wen Wang

doi:10.3978/j.issn.2305-5839.2016.02.04

New horizons of non-emergent use of extracorporeal membranous oxygenator support

Ann Transl Med. 2016 Feb;4(4):76. doi: 10.3978/j.issn.2305-5839.2016.02.04.

Authors

George Makdisi¹, Peter B Makdisi¹, I-Wen Wang¹

Affiliation

¹ 1 Gulf Coast Cardiothoracic Surgery Institute, Tampa General Hospital, Tampa, FL, USA ; 2 Mayo Clinic College of Medicine, Rochester, MN, USA ; 3 Indiana University School of Medicine, Division of Cardiothoracic Surgery, Indiana University Health, Methodist Hospital, Indianapolis, IN, USA.

PMID: 27004223
PMCID: PMC4779774
DOI: 10.3978/j.issn.2305-5839.2016.02.04

Abstract

The expansion of the extra corporeal membrane oxygenation (ECMO) use and its indication is strikingly increased in the past few years. ECMO use expanded to lung transplantation, difficult general thoracic resections, transcatheter aortic valve replacement (TAVR) and LVAD implantation. Here we will discuss the indications and the outcomes of non-emergent use of ECMO.

Keywords: Extra corporeal membrane oxygenation (ECMO); LVAD; TAVI; lung transplant; transcatheter aortic valve replacement (TAVR).

Publication types

Review